#Japan #liver fibrosis #Chiyoda #CMC Research #nucleic acids

Online Seminar on Novel Nucleic Acid Treatments for Liver Fibrosis

Date & Time: May 22, 2025, from 1:30 PM to 4:30 PM (JST)
Organizer: CMC Research Co., Ltd.
Location: Online via Zoom

CMC Research, a leader in providing cutting-edge technology and market information, will host an online seminar titled "Developing Oral Nucleic Acid Treatments for Liver Fibrosis". This exciting event will feature Professor Yoshimoto Murakami from Tokyo Medical University, who is renowned for his research in advanced nucleic acid therapies.

Purpose of the Seminar

Chronic liver diseases often lead to the progression of liver fibrosis over time, which, while not directly symptomatic, can result in severe complications such as liver cirrhosis and increased cancer risk. Therefore, controlling fibrosis before it advances to cirrhosis is crucial. The seminar will discuss the mechanisms of liver fibrosis and propose innovative nucleic acid-based therapies aimed at prevention and improvement.

Knowledge Gained from the Seminar

Participants will gain insights into:

• - Current diagnostic and therapeutic approaches for liver fibrosis based on clinical practices.
• - A comprehensive overview of the challenges and opportunities in developing nucleic acid therapies.
• - An understanding of the relevance of chronic liver disorders in the context of nucleic acid drug discovery.

The session will also include a Q&A segment, offering attendees a unique opportunity to interact directly with the expert lecturer.

Seminar Agenda

1. Significance of Diagnosing and Treating Liver Fibrosis in Chronic Liver Diseases
- Discussing advantages and disadvantages of diagnostic methods using blood tests, imaging, and pathological tissue assessment.
- Examining biological changes associated with severe liver disorders.

2. Current Treatments for Liver Fibrosis
- Analyzing the role of antiviral drugs, hepatoprotective agents, and amino acid formulations in current treatment strategies.

3. Objectives and Overview of Developing New Treatment Methods
- Proposing new approaches tailored for cirrhotic patients while considering the limitations of existing treatments.
- Developing drug delivery systems (DDS) and monitoring nucleic acid metabolism in vivo.

Enrollment Details

The seminar is priced at ¥44,000 (tax included), with discounted rates for CMC Research newsletter subscribers at ¥39,600 and an academic rate at ¥26,400.
To register, please visit CMC Research’s official site and follow the instructions for the seminar. A follow-up email containing the viewing URL will be provided to registered participants. Please note that recording or taking photographs during the session is prohibited.

Instructor Profile

Professor Yoshimoto Murakami
Professor of Advanced Nucleic Acid Medicine at Tokyo Medical University

• - Graduated from Kanazawa University School of Medicine in 1992.
• - He has served in various prestigious roles, including positions at renowned institutions such as the French National Institute for Health and Medical Research and Kyoto University.

Join us in this informative seminar to explore the forefront of liver disease research and treatment. Whether you are a professional interested in chronic liver conditions or in the field of nucleic acid drug development, this seminar promises to enhance your understanding and expertise in addressing these vital health challenges.